http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104825464-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104825464-B |
| titleOfInvention | CDCA is preparing the application in treating medicine for treating arthritis |
| abstract | The present invention relates to monomeric compound CDCA new application, and in particular to medicine for treating arthritis composition is treated in applications and one kind of the CDCA in treatment medicine for treating arthritis is prepared.General medicinal auxiliary element can be added by the CDCA of purity more than 98% by treating medicine for treating arthritis composition, and injection, tablet, capsule, electuary, drops, granule or ointment is made.Situations such as the pharmacological results show, CDCA can be obviously improved osteoarthritis position cell infiltration, proliferation of fibrous tissue and cartilage surface damage, reduce MMP 1, the β of MMP 3, IL 1 and PGE in joint fluid 2 Level, CDCA has the function that potent anti-Osteoarthritis.Therefore, CDCA can be used for the medicine for preparing treatment Osteoarthritis.The present invention provides new medicament sources for the treatment of Osteoarthritis. |
| priorityDate | 2015-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 16.